Elevai Labs, Inc. (ELAB)
NASDAQ: ELAB · IEX Real-Time Price · USD
0.689
+0.008 (1.25%)
May 20, 2024, 1:51 PM EDT - Market open

Elevai Labs Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022
Market Capitalization
1232-
Enterprise Value
1129-1
PE Ratio
-2.61-7.36-
PS Ratio
5.5518.50-
PB Ratio
4.888.28-
P/FCF Ratio
--6.94-
P/OCF Ratio
--6.95-
EV/Sales Ratio
5.2016.68-1.14
EV/EBITDA Ratio
--6.690.49
EV/EBIT Ratio
-2.46-6.670.48
EV/FCF Ratio
--6.250.54
Debt / Equity Ratio
0.070.050.25
Debt / EBITDA Ratio
--0.05-0.16
Debt / FCF Ratio
--0.05-0.18
Quick Ratio
0.822.591.99
Current Ratio
2.573.792.64
Asset Turnover
0.690.480.60
Interest Coverage
-113.24-219.31-683.77
Return on Equity (ROE)
-297.10%-173.50%-227.60%
Return on Assets (ROA)
-145.00%-121.50%-140.70%
Return on Capital (ROIC)
-172.68%-93.13%-126.42%
Earnings Yield
-38.09%-13.58%-
FCF Yield
-14.42%-
Buyback Yield / Dilution
-78.52%-12.77%-0.72%
Total Shareholder Return
-78.52%-12.77%-0.72%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).